COMPANY PROFILE // THE 014 REPORT
Medifast Inc.
MED (NYSE) · Formerly: HEALTHRITE INC
Assembled from 3 government sources in 0.2 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
- Amber4 8-K Item 5.02 filings (officer or director departures or appointments) in the last 12 months, most recently 2026-06-01: a pattern of leadership change.
- AmberLEI 5299000YHQJ21T5KKI80 registration status is LAPSED (last update 2021-07-13): the legal-entity record has not been renewed.
- InfoGLEIF: no direct parent reported; reporting exception reason NON_CONSOLIDATING.
✓ SEC filings✓ LEI✗ SAM registration✗ IRS return✗ State registration✗ Website✗ Lobbying registration
No SAM registration, no IRS return, no state registration, no website, no lobbying registration on record.
MEDIFAST INC is an SEC-registered operating company in miscellaneous food preparations & kindred products, incorporated in DE, based in Baltimore, MD; listed as MED (NYSE).[source] It reported revenue of $385.8 million for the fiscal year ended 2025-12-31.[source] It has filed 53 documents with the SEC in the last 12 months; the latest is a SCHEDULE 13G/A, filed 2026-11-16.[source] Its largest institutional holders on 13F filings are RENAISSANCE TECHNOLOGIES LLC, Steamboat Capital Partners, LLC, TWO SIGMA INVESTMENTS, LP (as of 2026-06-30).[source] Seraphix flags 2 items from these records: 4 8-K Item 5.02 filings (officer or director departures or appointments) in the last 12 months, most recently 2026-06-01; LEI 5299000YHQJ21T5KKI80 registration status is LAPSED (last update 2021-07-13).[source]
- red0
- amber2
- info1
- RENAISSANCE TECHNOLOGIES LLC$8.3M
- Steamboat Capital Partners, LLC$7.5M
- TWO SIGMA INVESTMENTS, LP$5.1M
- VANGUARD CAPITAL MANAGEMENT LLC$4.7M
- CHARLES SCHWAB INVESTMENT MANAGEMENT INC$4.2M
- BlackRock, Inc.$3.9M
- DIMENSIONAL FUND ADVISORS LP$3.9M
- AMERICAN CENTURY COMPANIES INC$3.4M
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Medifast, Inc. is an American nutrition and weight loss company based in Baltimore, Maryland. Medifast produces, distributes, and sells weight loss and health-related products through websites, multi-level marketing, telemarketing, and franchised weight loss clinics. (Wikipedia, CC BY-SA 4.0)
Officers and directors (Forms 3, 4, 5)
- Chard Daniel R · Chairman & CEO (Director,Officer) · latest Form 4 2026-03-27 · filing · LinkedIn search
- Johnson Nicholas Mark · President (Officer) · latest Form 3 2026-03-27 · filing · LinkedIn search
- MacKenzie Jonathan Barrett · VP, Finance & CAO (Officer) · latest Form 4 2026-03-27 · filing · LinkedIn search
- Maloney James P. · Chief Financial Officer (Officer) · latest Form 4 2026-03-27 · filing · LinkedIn search
- BROWN JEFFREY J · Director · latest Form 4 2025-06-26 · filing · LinkedIn search
- Geary Elizabeth A. · Director · latest Form 4 2025-06-26 · filing · LinkedIn search
- Hoer Michael A. · Director · latest Form 4 2025-06-26 · filing · LinkedIn search
- SCHLACKMAN SCOTT · Director · latest Form 4 2025-06-26 · filing · LinkedIn search
- Thomas Andrea B · Director · latest Form 4 2025-06-26 · filing · LinkedIn search
- Xian Ming · Director · latest Form 4 2025-06-26 · filing · LinkedIn search
As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.
Links
- Official website (Wikidata or the SEC record)
- Wikipedia
- Wikidata
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 25 CLEAR, 1 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0000910329 | source |
| LEI | 5299000YHQJ21T5KKI80 | source |
| EIN | 13-3714405 | source |
| Business address (SEC) | 1501 S. CLINTON STREET, BALTIMORE, MD, 21224 | source |
Does not exist in the records we hold: UEI, NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2019-11-02 · in -2,575 days · LEI next renewal (5299000YHQJ21T5KKI80)
- 2027-03-16 · in 116 days · Next 10-K due (period ended 2026-12-31; Accelerated filer<br>Smaller reporting company) (computed from the fiscal year end and filer status)
- 2027-05-10 · in 171 days · Next 10-Q due (period ended 2027-03-31; Accelerated filer<br>Smaller reporting company) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 2090 (miscellaneous food preparations & kindred products): 5 companies in our records share this code.
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- MCCORMICK & CO INC · 190 SEC filings in 12 months · 2 flags
- Utz Brands, Inc. · 78 SEC filings in 12 months
- MEDIFAST INC · 53 SEC filings in 12 months · 2 flags
- Top Wealth Group Holding Ltd · 48 SEC filings in 12 months · 1 flag
- COFFEE HOLDING CO INC · 19 SEC filings in 12 months · 4 flags
ADDRESS · ZIP CODE
Location context
At the same address (2)
- SERVICE BENEFIT PLAN ADMINISTRATIVE SERVICES CORPORATION VEBA · IRS-registered organization
SHARED PEOPLE · SHARED ADDRESS
Network neighbours
Shared directors and officers
- UPBOUND GROUP, INC. · BROWN JEFFREY J
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-10-26 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-10-26 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-09-29 filing 144 · SEC EDGAR
- 2026-09-28 filing 144 · SEC EDGAR
- 2026-08-21 filing SCHEDULE 13D/A · SEC EDGAR
- 2026-08-03 filing S-8 · SEC EDGAR
- 2026-08-03 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-08-03 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-07-17 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2026-07-10 filing 3/A · SEC EDGAR
- 2026-06-01 officer change 8-K items 5.02,9.01 · SEC EDGAR
- 2026-05-26 officer change 8-K items 5.02,5.07,7.01,9.01 · SEC EDGAR
- 2026-05-04 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-05-04 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-04-30 filing DEFA14A · SEC EDGAR
- 2026-04-06 filing ARS · SEC EDGAR
- 2026-04-06 filing DEFA14A · SEC EDGAR
- 2026-04-06 filing Proxy statement · SEC EDGAR
- 2026-03-27 insider First Form 3/4/5 on record for Johnson Nicholas Mark (President) · SEC Forms 3/4/5
- 2026-03-27 insider First Form 3/4/5 on record for MacKenzie Jonathan Barrett (VP, Finance & CAO) · SEC Forms 3/4/5
- 2026-03-27 insider First Form 3/4/5 on record for Maloney James P. (Chief Financial Officer) · SEC Forms 3/4/5
- 2026-03-20 filing SCHEDULE 13D · SEC EDGAR
- 2026-03-20 officer change 8-K items 1.01,5.02,7.01,9.01 · SEC EDGAR
- 2026-02-17 filing Annual report (10-K) · SEC EDGAR
- 2026-02-17 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2026-01-05 officer change 8-K items 5.02,9.01 · SEC EDGAR
- 2025-11-03 filing Quarterly report (10-Q) · SEC EDGAR
- 2025-11-03 filing 8-K items 2.02,9.01 · SEC EDGAR
- 2025-08-04 filing S-8 · SEC EDGAR
- 2025-08-04 filing Quarterly report (10-Q) · SEC EDGAR
135 earlier entries
- 2025-08-04 filing 8-K items 2.02,9.01
- 2025-06-26 insider First Form 3/4/5 on record for BROWN JEFFREY J (Director)
- 2025-06-26 insider First Form 3/4/5 on record for Geary Elizabeth A. (Director)
- 2025-06-26 insider First Form 3/4/5 on record for Hoer Michael A. (Director)
- 2025-06-26 insider First Form 3/4/5 on record for SCHLACKMAN SCOTT (Director)
- 2025-06-26 insider First Form 3/4/5 on record for Thomas Andrea B (Director)
- 2025-06-26 insider First Form 3/4/5 on record for Xian Ming (Director)
- 2025-06-20 officer change 8-K items 5.02,5.07,9.01
- 2025-06-17 insider First Form 3/4/5 on record for Chard Daniel R (Chairman & CEO)
- 2025-05-05 filing ARS
- 2025-04-29 filing DEFA14A
- 2025-04-29 filing Proxy statement
- 2025-04-28 filing Quarterly report (10-Q)
- 2025-04-28 filing 8-K items 2.02,9.01
- 2025-02-18 filing Annual report (10-K)
- 2025-02-18 filing 8-K items 2.02,9.01
- 2025-01-13 filing UPLOAD
- 2025-01-02 filing CORRESP
- 2024-12-19 filing UPLOAD
- 2024-11-26 filing CORRESP
- 2024-11-18 filing UPLOAD
- 2024-11-04 filing Quarterly report (10-Q)
- 2024-11-04 filing 8-K items 1.02,2.02
- 2024-10-31 filing S-8
- 2024-10-30 filing CORRESP
- 2024-10-17 filing UPLOAD
- 2024-08-05 filing Quarterly report (10-Q)
- 2024-08-05 filing 8-K items 2.02,9.01
- 2024-06-21 officer change 8-K items 5.02,5.07,9.01
- 2024-05-08 filing ARS
- 2024-04-29 filing Quarterly report (10-Q)
- 2024-04-29 filing 8-K items 2.02,9.01
- 2024-04-26 filing DEFA14A
- 2024-04-26 filing Proxy statement
- 2024-03-08 filing 144
- 2024-02-20 filing 8-K items 2.02,9.01
- 2024-02-20 filing Annual report (10-K)
- 2023-12-13 filing 8-K items 8.01,9.01
- 2023-11-06 filing Quarterly report (10-Q)
- 2023-11-06 filing 8-K items 2.02,9.01
- 2023-09-27 filing 8-K items 7.01,9.01
- 2023-09-07 filing 8-K items 8.01,9.01
- 2023-08-14 filing 144
- 2023-08-07 filing 8-K items 2.02,9.01
- 2023-08-07 filing Quarterly report (10-Q)
- 2023-06-15 filing 8-K items 5.07,8.01,9.01
- 2023-06-01 filing 8-K items 7.01,9.01
- 2023-05-01 filing Quarterly report (10-Q)
- 2023-05-01 filing 8-K items 2.02,9.01
- 2023-05-01 filing Proxy statement
- 2023-05-01 filing DEFA14A
- 2023-05-01 filing ARS
- 2023-04-20 officer change 8-K items 5.02,9.01
- 2023-03-16 filing 8-K items 8.01,9.01
- 2023-02-21 filing Annual report (10-K)
- 2023-02-21 filing 8-K items 2.02,9.01
- 2022-12-08 filing 8-K items 8.01,9.01
- 2022-11-03 filing Quarterly report (10-Q)
- 2022-11-03 filing 8-K items 2.02,9.01
- 2022-09-08 filing 8-K items 8.01
- 2022-08-03 filing Quarterly report (10-Q)
- 2022-08-03 filing 8-K items 2.02,9.01
- 2022-06-16 officer change 8-K items 5.02,5.07,8.01,9.01
- 2022-06-03 filing 8-K items 1.01,2.03,9.01
- 2022-06-01 filing 8-K items 8.01
- 2022-05-02 filing Quarterly report (10-Q)
- 2022-05-02 filing 8-K items 2.02,9.01
- 2022-04-21 filing DEFA14A
- 2022-04-21 filing Proxy statement
- 2022-03-17 filing 8-K items 8.01,9.01
- 2022-02-23 filing Annual report (10-K)
- 2022-02-23 filing 8-K items 2.02,9.01
- 2021-12-08 filing 8-K items 8.01,9.01
- 2021-11-04 filing Quarterly report (10-Q)
- 2021-11-04 filing 8-K items 2.02,9.01
- 2021-09-13 officer change 8-K items 5.02,9.01
- 2021-09-09 filing 8-K items 8.01,9.01
- 2021-09-01 officer change 8-K/A items 5.02,9.01
- 2021-08-05 officer change 8-K items 5.02,9.01
- 2021-08-04 filing Quarterly report (10-Q)
- 2021-08-04 filing 8-K items 2.02,9.01
- 2021-06-03 filing 8-K items 5.07,8.01,9.01
- 2021-05-04 filing Quarterly report (10-Q)
- 2021-05-04 filing 8-K items 2.02,9.01
- 2021-04-19 filing 8-K items 1.01,2.03,9.01
- 2021-04-15 filing DEFA14A
- 2021-04-15 filing Proxy statement
- 2021-03-18 filing 8-K items 8.01,9.01
- 2021-02-26 filing Annual report (10-K)
- 2021-02-25 filing 8-K items 2.02,9.01
- 2021-01-08 filing 8-K items 7.01,9.01
- 2020-12-10 officer change 8-K items 5.02,8.01,9.01
- 2020-11-03 filing Quarterly report (10-Q)
- 2020-11-02 filing 8-K items 2.02,9.01
- 2020-09-10 officer change 8-K items 5.02,8.01,9.01
- 2020-08-06 filing Quarterly report (10-Q)
- 2020-08-05 filing 8-K items 2.02,9.01
- 2020-07-20 officer change 8-K items 5.02,9.01
- 2020-07-15 filing SC 13D/A
- 2020-07-10 filing SC 13D/A
- 2020-06-16 filing 8-K items 5.07,8.01,9.01
- 2020-05-06 filing Quarterly report (10-Q)
- 2020-05-05 filing 8-K items 2.02,9.01
- 2020-04-28 filing DEFA14A
- 2020-04-28 filing Proxy statement
- 2020-04-03 officer change 8-K/A items 5.02,9.01
- 2020-03-19 filing 8-K items 8.01,9.01
- 2020-03-05 officer change 8-K items 5.02,7.01,9.01
- 2020-03-02 filing Annual report (10-K)
- 2020-02-26 filing 8-K items 2.02,9.01
- 2020-02-05 officer change 8-K items 5.02,9.01
- 2020-01-13 filing 8-K items 7.01,9.01
- 2019-12-13 filing 8-A12B/A
- 2019-12-13 filing 8-K items 1.01,3.03,9.01
- 2019-12-04 filing 8-K items 8.01,9.01
- 2019-12-04 filing 8-K/A items 9.01
- 2019-11-27 filing CERT
- 2019-11-22 filing 8-A12B
- 2019-11-22 filing 8-K items 1.01,3.03,5.03,8.01,9.01
- 2019-11-18 filing SC 13D
- 2019-11-08 filing Quarterly report (10-Q)
- 2019-11-07 filing 8-K items 2.02,9.01
- 2019-09-12 officer change 8-K items 5.02,8.01,9.01
- 2019-08-02 filing Quarterly report (10-Q)
- 2019-08-01 filing 8-K items 2.02,9.01
- 2019-06-13 filing 8-K items 5.03,5.07,8.01,9.01
- 2019-05-02 filing Quarterly report (10-Q)
- 2019-05-01 filing 8-K items 2.02,9.01
- 2019-04-22 filing DEFA14A
- 2019-04-22 filing Proxy statement
- 2019-03-13 filing 8-K items 8.01,9.01
- 2019-03-01 filing Annual report (10-K)
- 2019-02-26 filing 8-K items 2.02,9.01
- 2019-02-15 filing 5/A
- 2001-01-09 name change Name changed from HEALTHRITE INC
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-10-26 (within 30 days) 10-Q filed
- 2026-10-26 (within 30 days) 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-08-03 (older) S-8 filed
- 2026-08-03 (older) 10-Q filed
- 2026-08-03 (older) 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-07-17 (older) 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-06-01 (older) 8-K filed: Item 5.02 officer or director change; Item 9.01 exhibits
- 2026-05-26 (older) 8-K filed: Item 5.02 officer or director change; Item 5.07 shareholder vote; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-19; the colour is also written out in words.
COUNTS FROM THIS PAGERelationships at a glance
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- NYSE:MED The chart widget (TradingView) shows the price and the previous session's close. Seraphix publishes no price of its own.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
2 possible matches held apart, matched by name only, not counted above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 910329 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | MED / NYSE | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| LEI (root of the ownership tree) | 5299000YHQJ21T5KKI80 | id:lei-family: legal entity in this company's GLEIF ownership tree (LEI 5299000YHQJ21T5KKI80) | GLEIF |
| EIN | 133714405 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0000910329 | SEC EDGAR / IRS |
| CUSIP | 58470H101 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0000910329 | SEC EDGAR |
possible match: matched by name only, not merged (1)
Identifiers carried by records that share the company's exact name. Not merged into the identity above.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| EPA FRS id | 110043546749 (MEDIFAST INC (JASON PHARMACEUTICALS)) | name-exact:legal-name: same registered legal name as 'MEDIFAST INC' | EPA ECHO facilities |
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Revenue (fiscal year ended 2025-12-31) | $385,788,000 | 2025-12-31 | 10-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax | as filed | 2026-11-19 22:42 UTC | Report an error |
| Net income (loss) (fiscal year ended 2025-12-31) | -$18,672,000 | 2025-12-31 | 10-K, XBRL NetIncomeLoss | as filed | 2026-11-19 22:42 UTC | Report an error |
| Total assets (at 2025-12-31) | $247,973,000 | 2025-12-31 | 10-K, XBRL Assets | as filed | 2026-11-19 22:42 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | $198,920,000 | 2025-12-31 | 10-K, XBRL StockholdersEquity | as filed | 2026-11-19 22:42 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $89,303,000 | 2025-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | as filed | 2026-11-19 22:42 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-19 22:42 UTC | Report an error |
| SIC industry | 2090 Miscellaneous Food Preparations & Kindred Products | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-19 22:42 UTC | Report an error |
| State of incorporation | DE | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-19 22:42 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-19 22:42 UTC | Report an error |
| Business address | 1501 S. CLINTON STREET, SUITE 500, BALTIMORE, MD, 21224 | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-19 22:42 UTC | Report an error |
| Exchanges | NYSE | 2026-11-16 | SEC EDGAR company profile | as filed | 2026-11-19 22:42 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Operating cash flow (fiscal year ended 2025-12-31) | $6,863,000 | 2025-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | as filed | 2026-11-19 22:42 UTC | Report an error |
| Capital expenditures (property, plant and equipment) (fiscal year ended 2025-12-31) | $5,614,000 | 2025-12-31 | 10-K, XBRL PaymentsToAcquirePropertyPlantAndEquipment | as filed | 2026-11-19 22:42 UTC | Report an error |
| Operating lease liabilities (at 2025-12-31) | $10,694,000 | 2025-12-31 | 10-K, XBRL OperatingLeaseLiability | as filed | 2026-11-19 22:42 UTC | Report an error |
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-10-26 · accession 0001628280-26-067165
| Item | Value | Period | Form | Filed | Accession | Retrieved | Report |
|---|---|---|---|---|---|---|---|
| Revenue | $72,048,000 | 3 months ended 2026-09-30 | 10-Q | 2026-10-26 | 0001628280-26-067165 | 2026-11-19 22:42 UTC | Report an error |
| Net income (loss) | -$17,511,000 | 3 months ended 2026-09-30 | 10-Q | 2026-10-26 | 0001628280-26-067165 | 2026-11-19 22:42 UTC | Report an error |
| Cash and cash equivalents | $58,372,000 | at 2026-09-30 | 10-Q | 2026-10-26 | 0001628280-26-067165 | 2026-11-19 22:42 UTC | Report an error |
| Contract liabilities, current (from an earlier report) | $384,000 | at 2025-12-31 | 10-K | 2026-02-17 | 0001628280-26-008656 | 2026-11-19 22:42 UTC | Report an error |
Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-10-26 Filing 10-Q filed
- 2026-10-26 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-08-03 Filing S-8 filed
- 2026-08-03 Filing 10-Q filed
- 2026-08-03 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-07-17 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-06-01 Filing 8-K filed: Item 5.02 officer or director change; Item 9.01 exhibits
- 2026-05-26 Filing 8-K filed: Item 5.02 officer or director change; Item 5.07 shareholder vote; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-05-04 Filing 10-Q filed
- 2026-05-04 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-04-30 Filing DEFA14A filed
- 2026-04-06 Filing ARS filed
- 2026-04-06 Filing DEFA14A filed
- 2026-04-06 Filing DEF 14A filed
- 2026-03-20 Filing 8-K filed: Item 1.01 material agreement; Item 5.02 officer or director change; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-02-17 Filing 10-K filed
- 2026-02-17 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2026-01-05 Filing 8-K filed: Item 5.02 officer or director change; Item 9.01 exhibits
- 2025-11-03 Filing 10-Q filed
- 2025-11-03 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2025-08-04 Filing S-8 filed
- 2025-08-04 Filing 10-Q filed
- 2025-08-04 Filing 8-K filed: Item 2.02 results of operations; Item 9.01 exhibits
- 2025-06-20 Filing 8-K filed: Item 5.02 officer or director change; Item 5.07 shareholder vote; Item 9.01 exhibits
- 2025-05-05 Filing ARS filed
8-K item text, as filed (excerpts)
- 2026-10-26 8-K Item 2.02, Results of Operations and Financial Condition
On October 26, 2026, Medifast, Inc. (the "Company") issued a press release announcing its earnings for the third quarter ended September 30, 2026. A copy of the press release is being furnished as Exhibit 99.1 attached hereto and is incorporated by reference herein. This information is being furnished in this report and shall not be deemed to be "filed" for any purpose, including for the purpose of Section 18 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1993, as amended, or the Exchange Act, except as shall be… the 8-K · retrieved 2026-11-19 22:42 UTC - 2026-08-03 8-K Item 2.02, Results of Operations and Financial Condition
On August 3, 2026, Medifast, Inc. (the "Company") issued a press release announcing its earnings for the second quarter ended June 30, 2026. A copy of the press release is being furnished as Exhibit 99.1 attached hereto and is incorporated by reference herein. This information is being furnished in this report and shall not be deemed to be "filed" for any purpose, including for the purpose of Section 18 of the Securities and Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference into any filing under the Securities Act of 1993, as amended, or the Exchange Act, except as shall be… the 8-K · retrieved 2026-11-19 22:42 UTC
Each excerpt is the first part of the item's own text, copied as filed and cut at a word; the filing has the rest.
POSSIBLE MATCHES · GROUPED BY SOURCE8. Enforcement by agency
EPA ECHO facilities (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchMEDIFAST INC (JASON PHARMACEUTICALS) · exact legal name · sx:epa:110043546749 Compare
Each record's own page holds its date and the agency document. Matched by exact name only; none of these is counted in the headline.
AS FILED · LARGEST HOLDERS10. 13F institutional holders
| Rank | Holder (13F filer) | Value held | As of | Source | Retrieved | Report |
|---|---|---|---|---|---|---|
| 1 | RENAISSANCE TECHNOLOGIES LLC | $8,261,052 | 2026-06-30 | SEC 13F filing | 2026-11-19 22:42 UTC | Report an error |
| 2 | Steamboat Capital Partners, LLC | $7,498,076 | 2026-06-30 | SEC 13F filing | 2026-11-19 22:42 UTC | Report an error |
| 3 | TWO SIGMA INVESTMENTS, LP | $5,107,452 | 2026-06-30 | SEC 13F filing | 2026-11-19 22:42 UTC | Report an error |
| 4 | VANGUARD CAPITAL MANAGEMENT LLC | $4,738,575 | 2026-06-30 | SEC 13F filing | 2026-11-19 22:42 UTC | Report an error |
| 5 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $4,212,128 | 2026-06-30 | SEC 13F filing | 2026-11-19 22:42 UTC | Report an error |
| 6 | BlackRock, Inc. | $3,920,427 | 2026-06-30 | SEC 13F filing | 2026-11-19 22:42 UTC | Report an error |
| 7 | DIMENSIONAL FUND ADVISORS LP | $3,855,669 | 2026-06-30 | SEC 13F filing | 2026-11-19 22:42 UTC | Report an error |
| 8 | AMERICAN CENTURY COMPANIES INC | $3,383,646 | 2026-06-30 | SEC 13F filing | 2026-11-19 22:42 UTC | Report an error |
| 9 | GOLDMAN SACHS GROUP INC | $2,579,132 | 2026-06-30 | SEC 13F filing | 2026-11-19 22:42 UTC | Report an error |
| 10 | MARSHALL WACE, LLP | $2,563,897 | 2026-06-30 | SEC 13F filing | 2026-11-19 22:42 UTC | Report an error |
13F as filed: the holder's own report of its position value at the quarter end.
GLEIF OWNERSHIP TREE · ID TIER11. Subsidiaries
1 legal entity in the company's GLEIF ownership tree, joined by LEI (an official identifier).
- Medifast, Inc. · LEI 5299000YHQJ21T5KKI80 · root
Exhibit 21 subsidiaries: not held yet.
POSSIBLE MATCHES · LICENCES, PERMITS, CITY AND STATE RECORDS13. Permits and local records
1 state and city record carry this company's exact name, from 1 source. Possible matches only.
ClinicalTrials.gov (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchMedifast, Inc. · exact legal name · sx:ctgov:he82c0af52ec846bd Compare
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/910329.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0000910329. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.